These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 8246705)

  • 41. Decision analysis of tamoxifen for the prevention of invasive breast cancer.
    Grann VR; Sundararajan V; Jacobson JS; Whang W; Heitjan DF; Antman KH; Neugut AI
    Cancer J; 2000; 6(3):169-78. PubMed ID: 10882333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markov Chain Monte Carlo simulation for projection of end stage renal disease patients in Greece.
    Rodina-Theocharaki A; Bliznakova K; Pallikarakis N
    Comput Methods Programs Biomed; 2012 Jul; 107(1):90-6. PubMed ID: 22024418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Searching for convergence in phylogenetic Markov chain Monte Carlo.
    Beiko RG; Keith JM; Harlow TJ; Ragan MA
    Syst Biol; 2006 Aug; 55(4):553-65. PubMed ID: 16857650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modelling heterotachy in phylogenetic inference by reversible-jump Markov chain Monte Carlo.
    Pagel M; Meade A
    Philos Trans R Soc Lond B Biol Sci; 2008 Dec; 363(1512):3955-64. PubMed ID: 18852097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Latent mixed Markov modelling of smoking transitions using Monte Carlo bootstrapping.
    Mannan HR; Koval JJ
    Stat Methods Med Res; 2003 Mar; 12(2):125-46. PubMed ID: 12665207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticoagulation: managing adverse events in patients receiving anticoagulation and perioperative care.
    Hawes EM; Viera AJ
    FP Essent; 2014 Jul; 422():31-9; quiz 40-3. PubMed ID: 25033004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physical time scale in kinetic Monte Carlo simulations of continuous-time Markov chains.
    Serebrinsky SA
    Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Mar; 83(3 Pt 2):037701. PubMed ID: 21517635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primer on medical decision analysis: Part 5--Working with Markov processes.
    Naimark D; Krahn MD; Naglie G; Redelmeier DA; Detsky AS
    Med Decis Making; 1997; 17(2):152-9. PubMed ID: 9107610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decision analysis and Markov modeling in urology.
    Hsieh MH; Meng MV
    J Urol; 2007 Nov; 178(5):1867-74. PubMed ID: 17868735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Markov simulation model for analyzing and forecasting the number of coronary artery revascularization procedures in Western Australia.
    Mannan HR; Knuiman M; Hobbs M
    Ann Epidemiol; 2007 Dec; 17(12):964-75. PubMed ID: 18022536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uncovering mental representations with Markov chain Monte Carlo.
    Sanborn AN; Griffiths TL; Shiffrin RM
    Cogn Psychol; 2010 Mar; 60(2):63-106. PubMed ID: 19703686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shunts in normal-pressure hydrocephalus: do we place too many or too few?
    Stein SC; Burnett MG; Sonnad SS
    J Neurosurg; 2006 Dec; 105(6):815-22. PubMed ID: 17405250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bayesian restoration of a hidden Markov chain with applications to DNA sequencing.
    Churchill GA; Lazareva B
    J Comput Biol; 1999; 6(2):261-77. PubMed ID: 10421527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Problems with determination of noncommunicating classes for Monte Carlo Markov chain applications in pedigree analysis.
    Jensen CS; Sheehan N
    Biometrics; 1998 Jun; 54(2):416-25. PubMed ID: 9629636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
    Vitale A; Farinati F; Burra P; Trevisani F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Missale G; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Chiaramonte M; Spolverato G; Cillo U;
    Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying category representations for complex stimuli using discrete Markov chain Monte Carlo with people.
    Hsu AS; Martin JB; Sanborn AN; Griffiths TL
    Behav Res Methods; 2019 Aug; 51(4):1706-1716. PubMed ID: 30761464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sacral neuromodulation for the treatment of fecal incontinence: analysis of cost-effectiveness.
    Indinnimeo M; Ratto C; Moschella CM; Fiore A; Brosa M; Giardina S
    Dis Colon Rectum; 2010 Dec; 53(12):1661-9. PubMed ID: 21178862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement.
    Dong H; Buxton M
    Int J Technol Assess Health Care; 2006; 22(2):191-202. PubMed ID: 16571195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.